Spectrum Pharmaceuticals Securities Settlement
Checked October 15, 2026 against the official notice · Edited by Ferhat Abdullahoglu
This settlement closed on October 12, 2026
If you filed, payments follow the court's final approval (hearing November 20, 2026). Companies with one settlement often face another.
If you purchased Spectrum Pharmaceuticals, Inc. common stock between May 12, 2022, and September 22, 2022, you may be entitled to a payment from this settlement. Your payment amount will depend on the number of valid claims and your transactions in Spectrum common stock, and can go up or down from the estimated average distribution of $0.08 per share.
Who qualifies
- From May 12, 2022.
- Anywhere in the United States.
- Products: Spectrum Pharmaceuticals, Inc. common stock (CUSIP: 84763A108).
“If you purchased Spectrum Pharmaceuticals, Inc.”From the court-approved notice
What you can get
Cash payment
estimated average distribution per share is approximately $0.08
Proof: Supporting documentation
Your pro rata share will depend on valid claims and transactions
What proof means here: valid Claim Form, with supporting documentation
These are the amounts the settlement publishes. Shares of a fund depend on how many people file: what pro rata means.
How to file
The claim deadline has passed. If you filed, payments follow the court's final approval.
Key dates
When settlements pay, and what can delay it.
Is this settlement legit?
Yes. It's a court-approved class action settlement in the United States District Court, Southern District of New York (case 22-cv-10292-VEC), run by Strategic Claims Services. The official site is strategicclaims.net. You never pay to file a claim. How to check a settlement notice.
Related settlements
ClaimWell summarizes the official notice so it's easier to read. It isn't legal advice; the official settlement site is the authority on who qualifies and what each claim pays.